To identify whether CXCL9 is able to enhance the cell invasion and migration, chemokine CXCL9 at different concentrations was added into the lower transwell chamber, ranging from 0 ng/ml to 200 ng/ml, and CD133+ liver cancer cells was added into the upper chamber. This evidence concerns the gene CXCL9 and liver cancer.